Unify our thinking and work together to ensure the successful acceptance of the National Engineering Laboratory.
The National Engineering Laboratory for Quality Control of Traditional Chinese Medicine convened its 2012 Board Meeting.
On 11 29, the 2012 Board of Directors of the National Engineering Laboratory for Traditional Chinese Medicine Quality Control convened at the Capital Hotel in Beijing.
Attendees included Honorary Chairman Xiu Laigui, Chairman Chen Shilin, Vice Chairmen Wang Zhiguang and Lan Qingshan, and Council members Lu Jianwei, Bian Baolin, Wang Zhimin, Xiao Hongbin, Zhao Runhuai, and Shi Meng. Also present were Ren Yuzhen and Gao Lu, Deputy Directors of the National Engineering Laboratory (NEL); Zhang Qiwei, Secretary of the Council; Li Ling, Deputy Director of Junzheng Pharmaceutical Group; Du Jie from China National Medicines Corporation; and Yan Lihua from the Institute of Traditional Chinese Medicine.
The meeting was chaired by Vice President Wang Zhiguang. First, President Chen Shilin delivered a welcome address. Subsequently, NEL Director Wang Zhimin presented a report covering the project's background, objectives and approval requirements, work completed to date, fund utilization, future plans, and acceptance arrangements. He also provided a detailed overview of the overall progress, achievements made, and areas for improvement. Deputy Directors Gao Lu and Ren Yuzhen supplemented the report with updates on incubation base construction led by Xiusheng Pharmaceutical Group and China National Medicines Corporation, as well as research progress.
The Council members fully recognized the achievements made in NEL's early-stage development and offered guidance on next steps. Honorary Chairman Xiu Laigui stated that to ensure standardized control and traceable quality management of Chinese medicinal materials from the source, a plan has been formulated to establish standardized production and processing bases in Bozhou. Additionally, an independent testing center will be established under NEL to pursue relevant international certifications. President Chen Shilin highlighted that NEL's future operational model and development trend will be corporate-based. Vice President Lan Qingshan emphasized the critical importance and strong market demand for rapid testing of Chinese medicinal materials and decoction pieces, urging NEL to achieve notable results in this area. Council member Lu Jianwei outlined the three key tasks for NEL's construction and provided suggestions on specific details regarding acceptance procedures.
In closing, Vice Chairman Wang Zhiguang delivered a summary speech, emphasizing the need to further strengthen industry-academia-research collaboration and extend its impact across the entire sector. By enhancing ties between the China Chamber of Commerce for Import and Export of Medicines & Health Products and pharmaceutical enterprises, we can better understand their actual needs, provide technical support and services, and leverage innovative thinking to ensure the successful completion and sustainable development of all engineering laboratory initiatives. He also directed the laboratory to consolidate and summarize the recommendations raised at the board meeting, using them as a foundation to develop next year's work plan.
